Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > IR news

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on May 16, 2023 10:12am

76 Views

Post# 35450138

RE:RE:RE:RE:RE:IR news

Thanks for looking that up, hopefully that was our first sign of some decisive action.

Kd5513 wrote:
She has pulled her profile from what I found, so it appears they finally fired her. I would think she took down to keep potential employers from seeing she has an average 8-10 months before getting canned or leaving employers. I would have commented yesterday but her final act was to get me suspended for a few days :)

<< Previous

Bullboard Posts

Next >>

Let's Invest: Are you prepared for do-it-yourself investing?